Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Antidepressant drugs (ADs) have been shown to activate BDNF (brain-derived neurotrophic factor) receptor TrkB in the rodent brain but the mechanism underlying this phenomenon remains unclear. ADs act as monoamine reuptake inhibitors and after prolonged treatments regulate brain bdnf mRNA levels indicating that monoamine-BDNF signaling regulate AD-induced TrkB activation in vivo. However, recent findings demonstrate that Trk receptors can be transactivated independently of their neurotrophin ligands. METHODOLOGY: In this study we examined the role of BDNF, TrkB kinase activity and monoamine reuptake in the AD-induced TrkB activation in vivo and in vitro by employing several transgenic mouse models, cultured neurons and TrkB-expressing cell lines. PRINCIPAL FINDINGS: Using a chemical-genetic TrkB(F616A) mutant and TrkB overexpressing mice, we demonstrate that ADs specifically activate both the maturely and immaturely glycosylated forms of TrkB receptors in the brain in a TrkB kinase dependent manner. However, the tricyclic AD imipramine readily induced the phosphorylation of TrkB receptors in conditional bdnf⁻/⁻ knock-out mice (132.4±8.5% of control; P = 0.01), indicating that BDNF is not required for the TrkB activation. Moreover, using serotonin transporter (SERT) deficient mice and chemical lesions of monoaminergic neurons we show that neither a functional SERT nor monoamines are required for the TrkB phosphorylation response induced by the serotonin selective reuptake inhibitors fluoxetine or citalopram, or norepinephrine selective reuptake inhibitor reboxetine. However, neither ADs nor monoamine transmitters activated TrkB in cultured neurons or cell lines expressing TrkB receptors, arguing that ADs do not directly bind to TrkB. CONCLUSIONS: The present findings suggest that ADs transactivate brain TrkB receptors independently of BDNF and monoamine reuptake blockade and emphasize the need of an intact tissue context for the ability of ADs to induce TrkB activity in brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a study by Rantamaki et al. (2011) showed a rapid action of imipramine on TrkB phosphorylation in either presence or absence of BDNF, suggesting that antidepressants do not require BDNF to activate TrkB, an effect that was independent of 5-HTT.”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Rantamaki et al. 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, the recent data suggesting that antidepressant could also directly transactivated TrkB (Rantamaki et al. 2011) point to this receptor as a main molecular target for treating depression.”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Rantamaki et al. 2011
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the tricyclic antidepressant imipramine (30 mg/kg i.p.) increased phosphorylation of TrkB (residue Y816) 30 minutes post-treatment in the PFC (Rantamäki et al., 2011).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Rantamäki et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“fluoxetine (30 mg/kg i.p.) also increased phosphorylation of TrkB one-hour post-treatment in the hippocampus of WT and serotonin transporter knockout mice”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Rantamäki et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“suggesting that antidepressants do not require BDNF to activate TrkB, an effect that was independent of 5-HTT.”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Rantamaki et al. 2011
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394 · cited 1×
“Brainderived neurotrophic factor (BDNF) is the main endogenous ligand for TrkB [3], but recent evidence demonstrates that TrkB can also be transactivated independently of BDNF or other neurotrophins through neuromodulator receptors [6,7] and small molecules [8,9].”
BackgroundA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 1×
“Moreover, chronic, but not acute, AD treatment increases BDNF synthesis in the rodent brain [16,35].”
BackgroundNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 2×
“Moreover, chronic, but not acute, AD treatment increases BDNF synthesis in the rodent brain [16,35].”
BackgroundNeurotrophins and Neuronal Plasticity
Thoenen, H. (1995) · Science · doi:10.1126/science.270.5236.593 · Cited by 1,927 · cited 1×
“differentiation, survival and plasticity throughout life [1–5].”
Neurotrophins as synaptic modulators
Poo, M.-M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049004 · Cited by 1,775 · cited 1×
“differentiation, survival and plasticity throughout life [1–5].”
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
The yin and yang of neurotrophin action
Lu, B., Pang, P. T., & Woo, N. H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1726 · Cited by 1,356 · cited 1×
“Since it has recently been suggested that pro and mature forms of BDNF might have different capacities to activate TrkB [27], we investigated the effects of acute antidepressant treatment on proBDNF cleavage in brain.”
BackgroundNEUROTROPHINS AND SYNAPTIC PLASTICITY
McAllister, A. K., Katz, L. C., & Lo, D. C. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.295 · Cited by 1,337 · cited 1×
“differentiation, survival and plasticity throughout life [1–5].”
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232 · cited 1×
“range upon a successful treatment with ADs [18,19].”
BackgroundIncreased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164 · cited 1×
“. Levels of BDNF are reduced in the brain and serum of depressed patients and the levels are returned back to normal range upon a successful treatment with ADs”
Background
Cited by
Items 101–124 of 124
Neurochemical Signaling in Depression: Impact of Target-Based Pharmaceuticals
Sharma, B., & Khushboo (2022) · Current Drug Therapy · doi:10.2174/1574885517666220817122840 · Cited by 4
Faron‐Górecka, A., Kuśmider, M., Gruca, P., Pabian, P., Korlatowicz, A., Solich, J., Kolasa, M., & Dziedzicka‐Wasylewska, M. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147948 · Cited by 3
Glycosylation and Depression—A Review
Yamagata, H., & Nakagawa, S. (2020) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.2002.1e · Cited by 3
Takenouchi, Y., Hosomichi, J., Angkanawaraphan, K., Maeda, H., Hong, H., Changsiripun, C., & Ono, T. (2025) · Sleep And Breathing · doi:10.1007/s11325-025-03382-4 · Cited by 1
“TrkB can be activated independently of BDNF by pharmacological agents, supporting the idea of receptor-level modulation as a key driver of plasticity [32].”
Molecular Modeling of the Pathogenetic Mechanisms of Neuropsychiatric Disorders
Abdurazakov, A., Abashkin, D. A., Semina, E. V., Chaika, Y. A., & Golimbet, V. E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083563 · Cited by 2
Ahmed, E., Tawfik, M. K., Essawy, S. S., Ahmed, A., & Hermans, E. (2018) · Egyptian Journal of Basic and Clinical Pharmacology · doi:10.11131/2018/101383 · Cited by 1
“In contrast, a considerable number of studies have shown that antidepressant treatment leads to TrkB receptor upregulation [30] and activation [37].”
Affect, Mood, Emotions: Depressive Disorders and Bipolar and Related Disorders
Leigh, H. (2014) · Springer eBooks · doi:10.1007/978-3-319-11005-9_15 · Cited by 2
Levy, M. J. F., Boulle, F., Emerit, M. B., Steinbusch, H. W. M., van den Hove, D., Kenis, G., & Lanfumey, L. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.11.540 · Cited by 1
Neurophysiological mechanisms of plasticity induced in adult brain
Popova, D. (2015) · Helda - University of Helsinki Institutional Repository · Cited by 3
Comment on: Antidepressants act by directly binding to TRKB neurotrophin receptors
Gold, P. W., & Wong, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02615-4 · Cited by 1
“It is also known that antidepressants increase the proliferation and survival of newly born dentate granule neurons [5, 6].”
Further Studies in Adenosinergic and Monoaminergic Mechanisms of Analgesia by Amitriptyline
Liu, J. (2012) · Library and Archives Canada (Government of Canada)
Piltonen, M. (2012) · Helda - University of Helsinki Institutional Repository
Deflesselle, É. (2015) · HAL
Suicidalité sous antidépresseurs : aspects cliniques et étude cas-témoin pharmacogénétique
Voegeli, G. (2015) · Cited by 1
Oliveira, K. S., Hounie, A. G., Cappi, C., & Diniz, J. B. (2016) · Jornal Brasileiro de Psiquiatria · doi:10.1590/0047-2085000000132 · Cited by 1
Prowse, N. A. (2017) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2017-12052
“FL overlapping with truncated TrkB proteins at approximately 105Kd in Western Blotting (Martin-Zanca et al., 1989; Rantamäki et al., 2011), which can make it difficult to discern the 95-100Kd band for”
BackgroundTemporal patterns of fluoxetine-induced plasticity in the mouse visual cortexPreprint
Steinzeig, A., Cannarozzo, C., & Ċastrén, E. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/487553
“, 2003; Duman & Monteggia, 2006; Björkholm & Monteggia, 2016), independently from serotonin transporter (Rantamäki et al., 2011).”
BackgroundGPCR and RTK Regulation in Neurons: The Impact of Stress on GPCR and RTK signalling and Crosstalk
Gondora, N. (2020) · UWSpace (University of Waterloo) · Cited by 1
Physiological basis underlying antidepressant-induced activation of TrkB receptorsPreprint
Alitalo, O., Kohtala, S., Rosenholm, M., Kohtala, P., Saarreharju, R., Matsui, N., González-Hernández, G., Müller, H. K., Theilmann, W., Sarparanta, M. P., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.30.458151
“Indeed, this report extends our previous observations suggesting a BDNF-independent mechanism underlying antidepressant-induced TrkB activation (Antila et al., 2017; Rantamäki et al., 2011).”
BackgroundResultInfluentialSelf-citationGlycosylation and Depression—A Review
Yamagata, H., & Nakagawa, S. (2020) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.2002.1j
Ng, Z. M. W. (2022) · Journal of Student Research · doi:10.47611/jsrhs.v11i4.3352
Epigenetic regulation of BDNF-TRKB signaling in the pathophysiology and treatment of mood disorders
Boulle, F. (2013) · theses.fr (ABES) · doi:10.70675/7796cc83z9f91z48c6zadb1zb6a90897b5d5
Lin, J., Wu, J., Wang, Y., Huo, Y., & Zhang, J. (2026) · iScience · doi:10.1016/j.isci.2026.117102
“38 Furthermore, increased receptor expression may itself elevate basal TrkB activity, as high-density receptors can undergo spontaneous dimerization and phosphorylation.”
Metadata
- Authors
- Rantamäki, T., Vesa, L., Antila, H., Di Lieto, A., Tammela, P., Schmitt, A., Lesch, K.-P., Rios, M., & Castrén, E.
- Affiliations
- University of Helsinki (FI)
- University of Würzburg (DE)
- Tufts University (US)
- Corresponding author
- Rantamäki, Tomi
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-06-07
- Volume
- 6
- Issue
- 6
- Pages
- e20567
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3110188
- OpenAlex
- W2019787596
- Cited by
- 124
- References
- 49
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 11 · 2021: 14 · 2020: 7 · 2019: 12 · 2018: 10 · 2017: 9 · 2016: 7 · 2015: 10 · 2014: 7 · 2013: 11 · 2012: 11
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by)
- Funders
- Helsingin Yliopisto
- Deutsche Forschungsgemeinschaft
- Suomen Kulttuurirahasto
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- antidepressants, TrkB receptor, brain-derived neurotrophic factor, receptor transactivation, monoamine reuptake inhibitors, serotonin transporter, imipramine, fluoxetine, citalopram, reboxetine, monoamine signaling, antidepressant mechanism
- MeSH terms
- Aging, Amitriptyline, Animals, Antidepressive Agents, Brain, Glycosylation, Imipramine, Mice, Inbred C57BL, Phosphorylation, Transcriptional Activation, Brain-Derived Neurotrophic Factor, Receptor, trkB, Serotonin Plasma Membrane Transport Proteins, Vesicular Monoamine Transport Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.